TGFB1 and breast carcinoma: Furthermore, two distinctive stem cell populations were identified in primary human breast cancer cells: CD44-, CD24+, ER+, TGFB-RII- or CD44+, CD24-, ER-, TGFB-RII+ with the latter only being able to undergo EMT due to TGF-β treatment [9].